AKT1 and rhabdomyosarcoma: The reason that Bazedoxifene didn’t inhibited P-AKT or P-ERK in all three rhabdomyosarcoma cell lines could be the activation of P-AKT or P-ERK not only depend on IL-6/GP130 signaling, but also depend on the stimulation of others cytokines or growth factor.